PPARβ/δ as a promising molecular drug target for liver diseases: A focused review - 17/04/24
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Highlights |
• | PPARβ/δ is expressed in various types of liver cells with higher expression in KCs and HSCs. |
• | Versatile functions of PPARβ/δ such as regulation of lipid and glucose metabolism and anti-inflammation have been reported. |
• | PPARβ/δ may serve as a potential molecular drug target for various liver diseases. |
Abstract |
Various liver diseases pose great threats to humans. Although the etiologies of these liver diseases are quite diverse, they share similar pathologic phenotypes and molecular mechanisms such as oxidative stress, lipid and glucose metabolism disturbance, hepatic Kupffer cell (KC) proinflammatory polarization and inflammation, insulin resistance, and hepatic stellate cell (HSC) activation and proliferation. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is expressed in various types of liver cells with relatively higher expression in KCs and HSCs. Accumulating evidence has revealed the versatile functions of PPARβ/δ such as controlling lipid homeostasis, inhibiting inflammation, regulating glucose metabolism, and restoring insulin sensitivity, suggesting that PPARβ/δ may serve as a potential molecular drug target for various liver diseases. This article aims to provide a concise review of the structure, expression pattern and biological functions of PPARβ/δ in the liver and its roles in various liver diseases, and to discuss potential future research perspectives.
Le texte complet de cet article est disponible en PDF.Keywords : Hepatotoxicants, Hepatic stellate cells, Kupffer cells, Liver disease, PPARβ/δ
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?